Drug company funding of drug trials greatly influences outcome
In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study, according to an analysis of nearly 200 statin-drug comparisons carried…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study, according to an analysis of nearly 200 statin-drug comparisons carried…
You must be logged in to post a comment.